Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-01 CHESS ROBERT Director Exercise or conversion · Stock Option −5,000 10,000
2016-05-17 Nicholson John SVP & Chief Financial Officer Sale −856 $13.58 $12K 77,630
2016-05-17 ROBIN HOWARD W President & CEO Sale −2,170 $13.58 $29K 16,933
2016-05-17 Doberstein Stephen K SVP & Chief Scientific Officer Sale −339 $13.58 $5K 1,021
2016-05-17 Gergel Ivan P. SVP & Chief Medical Officer Sale −432 $13.58 $6K 1,512
2016-05-17 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −835 $13.58 $11K 7,135
2016-05-17 Labrucherie Gil M SVP & General Counsel Sale −836 $13.58 $11K 7,921
2016-05-17 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −724 $13.58 $10K 6,309
2016-05-16 Nicholson John SVP & Chief Financial Officer Exercise or conversion +2,167 $0.00 $0 78,486
2016-05-16 Nicholson John SVP & Chief Financial Officer Returned to the company · Restricted Stock Unit −2,167 21,667
2016-05-16 ROBIN HOWARD W President & CEO Exercise or conversion +5,625 $0.00 $1 19,103
2016-05-16 ROBIN HOWARD W President & CEO Returned to the company · Restricted Stock Unit −5,625 56,250
2016-05-16 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +875 $0.00 $0 1,360
2016-05-16 Doberstein Stephen K SVP & Chief Scientific Officer Returned to the company · Restricted Stock Unit −875 8,750
2016-05-16 Gergel Ivan P. SVP & Chief Medical Officer Exercise or conversion +1,250 $0.00 $0 1,944
2016-05-16 Gergel Ivan P. SVP & Chief Medical Officer Returned to the company · Restricted Stock Unit −1,250 12,500
2016-05-16 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion +2,167 $0.00 $0 7,970
2016-05-16 Hora Maninder SVP Pharma Dev & Mfg Ops Returned to the company · Restricted Stock Unit −2,167 21,667
2016-05-16 Labrucherie Gil M SVP & General Counsel Exercise or conversion +2,167 $0.00 $0 8,757
2016-05-16 Labrucherie Gil M SVP & General Counsel Returned to the company · Restricted Stock Unit −2,167 21,667

Page 52 of 55 · 1,088 trades